Skip to main content
CTNM logo

CTNM · Contineum Therapeutics, Inc. · Executive Compensation

Track CTNM — free
$8.68 -0.36 (-3.98%) At close · Nov 20
Market Cap
$340.83M
Shares
39.27M
Volume · Nov 20 369.22K Avg daily vol (3M) 769.71K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Carmine N. Stengone $3,409,448
Timothy R. Watkins $1,763,323
Peter T. Slover $1,577,903
Fiscal 2024
Executive Total
Carmine N. Stengone $4,900,039
John S. Healy $2,562,489
Stephen L. Huhn $2,121,674
Fiscal 2023
Executive Total
Carmine N. Stengone $2,315,299

Executive changes

Person Change Filed
Diego Miralles, M.D. Appointed 2025-03-17
Sarah Boyce Appointed 2024-06-24
Troy Ignelzi Appointed 2024-05-20

Leadership

Key facts CIK 1855175 CUSIP 21217B100 13F (30d) 120 filings 113 filers Visit website Investor relations